RT @ebsummiteurope: MEP @spietikainen at the #HealthSummitEU2023 “All critical substances should be produced in the EU🇪🇺, starting from paracetamol to cancer medicine. In the case of a crisis, that would grant us a degree of autonomy.” https://t.co/Jl7Wb80BBN

🐦🔗: https://n.respublicae.eu/spietikainen/status/1666740202822410240

RT @ebsummiteurope: Policy Officer Lilia Luchianov from @EU_Health at the #HealthSummitEU2023: “Access, affordability and availability were the main homework for us when we first started drafting the #EUPharmaLegislation. At the same time, #innovation was something we had in mind throughout the… https://t.co/4KVSM5Zs5r https://t.co/EFLg6Qk2ef

🐦🔗: https://n.respublicae.eu/EU_Health/status/1666739499647348736

@ebsummiteurope @SandraGallina The #EUPharmaStrategy and #EHDS are important building blocks in the European #HealthUnion.
For both, we have a people centred approach, whilst also supporting innovation.
https://europa.eu/!7Kb3BR
#HealthSummitEU2023

🐦🔗: https://n.respublicae.eu/EU_Health/status/1666723568946692097

RT @ebsummiteurope: Join @EU_Health Director General @SandraGallina in her keynote on the #EUPharmaStrategy and the European Health Data Space 🇪🇺 at #HealthSummitEU2023 https://t.co/BnVFqsQ1DX

🐦🔗: https://n.respublicae.eu/EU_Health/status/1666720633550503937

RT @ebsummiteurope: “It’s important that we bear in mind two core elements of the #EUPharmaLegislation: a) access and affordability, and b) innovation” - @EU_Health DG @SandraGallina at #HealthSummitEU2023 https://t.co/6tsg2WwS70

🐦🔗: https://n.respublicae.eu/EU_Health/status/1666719950168268801